Treatment with Trikafta lowered the need for antibiotics and mucus-clearing therapies among children and adolescents with cystic fibrosisࢥing followed at a pediatric CF center in Utah.ࠊeffery T. Zobell, a clinical pharmacist at Primary Childrenҳ CF Center in Salt Lake City, shared the findings in the presentation ӂeyond PFTs: Elexacaftor/tezacaftor/ivacaftor outcomes in a pediatric CF [ŝThe post #NACFC2021 ֠Trikafta Lowers Need for Antibiotics, Mucus Clearance in Children appeared first on Cystic Fibrosis News Today